Chemical & Material
Global Retinol and Derivatives Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 570961
- Pages: 141
- Figures: 131
- Views: 1
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Retinol and Derivatives market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
DSM
BASF
Evonik
Zhejiang NHU
Adisseo
Zhejiang Pharmaceutical
XIAMEN KINGDOMWAY VITAMIN
Salvona Technologies
Piramal Group
Tagra Biotechnologies
Segment by Type
Retinol
Retinol Derivatives
Segment by Application
Animal Feed
Food
Cosmetics
Pharmaceuticals
Others
Production by Region
North America
Europe
China
India
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Retinol and Derivatives study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Retinol and Derivatives market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
DSM
BASF
Evonik
Zhejiang NHU
Adisseo
Zhejiang Pharmaceutical
XIAMEN KINGDOMWAY VITAMIN
Salvona Technologies
Piramal Group
Tagra Biotechnologies
Segment by Type
Retinol
Retinol Derivatives
Segment by Application
Animal Feed
Food
Cosmetics
Pharmaceuticals
Others
Production by Region
North America
Europe
China
India
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Retinol and Derivatives study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Retinol and Derivatives: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Retinol and Derivatives Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Retinol
1.2.3 Retinol Derivatives
1.3 Market Segmentation by Application
1.3.1 Global Retinol and Derivatives Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Animal Feed
1.3.3 Food
1.3.4 Cosmetics
1.3.5 Pharmaceuticals
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Retinol and Derivatives Revenue Estimates and Forecasts 2020-2031
2.2 Global Retinol and Derivatives Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Retinol and Derivatives Sales Estimates and Forecasts 2020-2031
2.4 Global Retinol and Derivatives Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Retinol and Derivatives Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 India
4 Competition by Manufacturers
4.1 Global Retinol and Derivatives Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Retinol and Derivatives Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Retinol Market Size by Manufacturers
4.5.2 Retinol Derivatives Market Size by Manufacturers
4.6 Global Retinol and Derivatives Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Retinol and Derivatives Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Retinol and Derivatives Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Retinol and Derivatives Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Retinol and Derivatives Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Retinol and Derivatives Sales and Revenue by Type (2020-2031)
7.4 North America Retinol and Derivatives Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Retinol and Derivatives Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Retinol and Derivatives Sales and Revenue by Type (2020-2031)
8.4 Europe Retinol and Derivatives Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Retinol and Derivatives Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Retinol and Derivatives Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Retinol and Derivatives Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Retinol and Derivatives Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Retinol and Derivatives Sales and Revenue by Type (2020-2031)
10.4 Central and South America Retinol and Derivatives Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Retinol and Derivatives Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Retinol and Derivatives Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Retinol and Derivatives Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Retinol and Derivatives Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 DSM
12.1.1 DSM Corporation Information
12.1.2 DSM Business Overview
12.1.3 DSM Retinol and Derivatives Product Models, Descriptions and Specifications
12.1.4 DSM Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 DSM Retinol and Derivatives Sales by Product in 2024
12.1.6 DSM Retinol and Derivatives Sales by Application in 2024
12.1.7 DSM Retinol and Derivatives Sales by Geographic Area in 2024
12.1.8 DSM Retinol and Derivatives SWOT Analysis
12.1.9 DSM Recent Developments
12.2 BASF
12.2.1 BASF Corporation Information
12.2.2 BASF Business Overview
12.2.3 BASF Retinol and Derivatives Product Models, Descriptions and Specifications
12.2.4 BASF Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 BASF Retinol and Derivatives Sales by Product in 2024
12.2.6 BASF Retinol and Derivatives Sales by Application in 2024
12.2.7 BASF Retinol and Derivatives Sales by Geographic Area in 2024
12.2.8 BASF Retinol and Derivatives SWOT Analysis
12.2.9 BASF Recent Developments
12.3 Evonik
12.3.1 Evonik Corporation Information
12.3.2 Evonik Business Overview
12.3.3 Evonik Retinol and Derivatives Product Models, Descriptions and Specifications
12.3.4 Evonik Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Evonik Retinol and Derivatives Sales by Product in 2024
12.3.6 Evonik Retinol and Derivatives Sales by Application in 2024
12.3.7 Evonik Retinol and Derivatives Sales by Geographic Area in 2024
12.3.8 Evonik Retinol and Derivatives SWOT Analysis
12.3.9 Evonik Recent Developments
12.4 Zhejiang NHU
12.4.1 Zhejiang NHU Corporation Information
12.4.2 Zhejiang NHU Business Overview
12.4.3 Zhejiang NHU Retinol and Derivatives Product Models, Descriptions and Specifications
12.4.4 Zhejiang NHU Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Zhejiang NHU Retinol and Derivatives Sales by Product in 2024
12.4.6 Zhejiang NHU Retinol and Derivatives Sales by Application in 2024
12.4.7 Zhejiang NHU Retinol and Derivatives Sales by Geographic Area in 2024
12.4.8 Zhejiang NHU Retinol and Derivatives SWOT Analysis
12.4.9 Zhejiang NHU Recent Developments
12.5 Adisseo
12.5.1 Adisseo Corporation Information
12.5.2 Adisseo Business Overview
12.5.3 Adisseo Retinol and Derivatives Product Models, Descriptions and Specifications
12.5.4 Adisseo Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Adisseo Retinol and Derivatives Sales by Product in 2024
12.5.6 Adisseo Retinol and Derivatives Sales by Application in 2024
12.5.7 Adisseo Retinol and Derivatives Sales by Geographic Area in 2024
12.5.8 Adisseo Retinol and Derivatives SWOT Analysis
12.5.9 Adisseo Recent Developments
12.6 Zhejiang Pharmaceutical
12.6.1 Zhejiang Pharmaceutical Corporation Information
12.6.2 Zhejiang Pharmaceutical Business Overview
12.6.3 Zhejiang Pharmaceutical Retinol and Derivatives Product Models, Descriptions and Specifications
12.6.4 Zhejiang Pharmaceutical Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Zhejiang Pharmaceutical Recent Developments
12.7 XIAMEN KINGDOMWAY VITAMIN
12.7.1 XIAMEN KINGDOMWAY VITAMIN Corporation Information
12.7.2 XIAMEN KINGDOMWAY VITAMIN Business Overview
12.7.3 XIAMEN KINGDOMWAY VITAMIN Retinol and Derivatives Product Models, Descriptions and Specifications
12.7.4 XIAMEN KINGDOMWAY VITAMIN Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 XIAMEN KINGDOMWAY VITAMIN Recent Developments
12.8 Salvona Technologies
12.8.1 Salvona Technologies Corporation Information
12.8.2 Salvona Technologies Business Overview
12.8.3 Salvona Technologies Retinol and Derivatives Product Models, Descriptions and Specifications
12.8.4 Salvona Technologies Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Salvona Technologies Recent Developments
12.9 Piramal Group
12.9.1 Piramal Group Corporation Information
12.9.2 Piramal Group Business Overview
12.9.3 Piramal Group Retinol and Derivatives Product Models, Descriptions and Specifications
12.9.4 Piramal Group Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Piramal Group Recent Developments
12.10 Tagra Biotechnologies
12.10.1 Tagra Biotechnologies Corporation Information
12.10.2 Tagra Biotechnologies Business Overview
12.10.3 Tagra Biotechnologies Retinol and Derivatives Product Models, Descriptions and Specifications
12.10.4 Tagra Biotechnologies Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Tagra Biotechnologies Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Retinol and Derivatives Industry Chain
13.2 Retinol and Derivatives Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Retinol and Derivatives Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Retinol and Derivatives Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Retinol and Derivatives Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Retinol and Derivatives Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
1.1 Introduction to Retinol and Derivatives: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Retinol and Derivatives Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Retinol
1.2.3 Retinol Derivatives
1.3 Market Segmentation by Application
1.3.1 Global Retinol and Derivatives Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Animal Feed
1.3.3 Food
1.3.4 Cosmetics
1.3.5 Pharmaceuticals
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Retinol and Derivatives Revenue Estimates and Forecasts 2020-2031
2.2 Global Retinol and Derivatives Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Retinol and Derivatives Sales Estimates and Forecasts 2020-2031
2.4 Global Retinol and Derivatives Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Retinol and Derivatives Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 India
4 Competition by Manufacturers
4.1 Global Retinol and Derivatives Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Retinol and Derivatives Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Retinol Market Size by Manufacturers
4.5.2 Retinol Derivatives Market Size by Manufacturers
4.6 Global Retinol and Derivatives Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Retinol and Derivatives Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Retinol and Derivatives Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Retinol and Derivatives Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Retinol and Derivatives Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Retinol and Derivatives Sales and Revenue by Type (2020-2031)
7.4 North America Retinol and Derivatives Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Retinol and Derivatives Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Retinol and Derivatives Sales and Revenue by Type (2020-2031)
8.4 Europe Retinol and Derivatives Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Retinol and Derivatives Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Retinol and Derivatives Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Retinol and Derivatives Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Retinol and Derivatives Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Retinol and Derivatives Sales and Revenue by Type (2020-2031)
10.4 Central and South America Retinol and Derivatives Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Retinol and Derivatives Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Retinol and Derivatives Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Retinol and Derivatives Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Retinol and Derivatives Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 DSM
12.1.1 DSM Corporation Information
12.1.2 DSM Business Overview
12.1.3 DSM Retinol and Derivatives Product Models, Descriptions and Specifications
12.1.4 DSM Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 DSM Retinol and Derivatives Sales by Product in 2024
12.1.6 DSM Retinol and Derivatives Sales by Application in 2024
12.1.7 DSM Retinol and Derivatives Sales by Geographic Area in 2024
12.1.8 DSM Retinol and Derivatives SWOT Analysis
12.1.9 DSM Recent Developments
12.2 BASF
12.2.1 BASF Corporation Information
12.2.2 BASF Business Overview
12.2.3 BASF Retinol and Derivatives Product Models, Descriptions and Specifications
12.2.4 BASF Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 BASF Retinol and Derivatives Sales by Product in 2024
12.2.6 BASF Retinol and Derivatives Sales by Application in 2024
12.2.7 BASF Retinol and Derivatives Sales by Geographic Area in 2024
12.2.8 BASF Retinol and Derivatives SWOT Analysis
12.2.9 BASF Recent Developments
12.3 Evonik
12.3.1 Evonik Corporation Information
12.3.2 Evonik Business Overview
12.3.3 Evonik Retinol and Derivatives Product Models, Descriptions and Specifications
12.3.4 Evonik Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Evonik Retinol and Derivatives Sales by Product in 2024
12.3.6 Evonik Retinol and Derivatives Sales by Application in 2024
12.3.7 Evonik Retinol and Derivatives Sales by Geographic Area in 2024
12.3.8 Evonik Retinol and Derivatives SWOT Analysis
12.3.9 Evonik Recent Developments
12.4 Zhejiang NHU
12.4.1 Zhejiang NHU Corporation Information
12.4.2 Zhejiang NHU Business Overview
12.4.3 Zhejiang NHU Retinol and Derivatives Product Models, Descriptions and Specifications
12.4.4 Zhejiang NHU Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Zhejiang NHU Retinol and Derivatives Sales by Product in 2024
12.4.6 Zhejiang NHU Retinol and Derivatives Sales by Application in 2024
12.4.7 Zhejiang NHU Retinol and Derivatives Sales by Geographic Area in 2024
12.4.8 Zhejiang NHU Retinol and Derivatives SWOT Analysis
12.4.9 Zhejiang NHU Recent Developments
12.5 Adisseo
12.5.1 Adisseo Corporation Information
12.5.2 Adisseo Business Overview
12.5.3 Adisseo Retinol and Derivatives Product Models, Descriptions and Specifications
12.5.4 Adisseo Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Adisseo Retinol and Derivatives Sales by Product in 2024
12.5.6 Adisseo Retinol and Derivatives Sales by Application in 2024
12.5.7 Adisseo Retinol and Derivatives Sales by Geographic Area in 2024
12.5.8 Adisseo Retinol and Derivatives SWOT Analysis
12.5.9 Adisseo Recent Developments
12.6 Zhejiang Pharmaceutical
12.6.1 Zhejiang Pharmaceutical Corporation Information
12.6.2 Zhejiang Pharmaceutical Business Overview
12.6.3 Zhejiang Pharmaceutical Retinol and Derivatives Product Models, Descriptions and Specifications
12.6.4 Zhejiang Pharmaceutical Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Zhejiang Pharmaceutical Recent Developments
12.7 XIAMEN KINGDOMWAY VITAMIN
12.7.1 XIAMEN KINGDOMWAY VITAMIN Corporation Information
12.7.2 XIAMEN KINGDOMWAY VITAMIN Business Overview
12.7.3 XIAMEN KINGDOMWAY VITAMIN Retinol and Derivatives Product Models, Descriptions and Specifications
12.7.4 XIAMEN KINGDOMWAY VITAMIN Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 XIAMEN KINGDOMWAY VITAMIN Recent Developments
12.8 Salvona Technologies
12.8.1 Salvona Technologies Corporation Information
12.8.2 Salvona Technologies Business Overview
12.8.3 Salvona Technologies Retinol and Derivatives Product Models, Descriptions and Specifications
12.8.4 Salvona Technologies Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Salvona Technologies Recent Developments
12.9 Piramal Group
12.9.1 Piramal Group Corporation Information
12.9.2 Piramal Group Business Overview
12.9.3 Piramal Group Retinol and Derivatives Product Models, Descriptions and Specifications
12.9.4 Piramal Group Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Piramal Group Recent Developments
12.10 Tagra Biotechnologies
12.10.1 Tagra Biotechnologies Corporation Information
12.10.2 Tagra Biotechnologies Business Overview
12.10.3 Tagra Biotechnologies Retinol and Derivatives Product Models, Descriptions and Specifications
12.10.4 Tagra Biotechnologies Retinol and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Tagra Biotechnologies Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Retinol and Derivatives Industry Chain
13.2 Retinol and Derivatives Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Retinol and Derivatives Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Retinol and Derivatives Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Retinol and Derivatives Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Retinol and Derivatives Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
Table 1. Global Retinol and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Retinol and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Retinol and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Retinol and Derivatives Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Retinol and Derivatives Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Retinol and Derivatives Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Retinol and Derivatives Sales by Region (2020-2025) & (Tons)
Table 8. Global Retinol and Derivatives Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Retinol and Derivatives Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Retinol and Derivatives Production by Region (2020-2025) & (Tons)
Table 12. Global Retinol and Derivatives Production by Region (2026-2031) & (Tons)
Table 13. Global Retinol and Derivatives Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Retinol and Derivatives Sales Share by Manufacturers (2020-2025)
Table 15. Global Retinol and Derivatives Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Retinol and Derivatives Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Retinol and Derivatives by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinol and Derivatives as of 2024)
Table 19. Global Retinol and Derivatives Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Retinol and Derivatives Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Retinol and Derivatives Manufacturing Base and Headquarters
Table 22. Global Retinol and Derivatives Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Retinol and Derivatives Sales by Type (2020-2025) & (Tons)
Table 26. Global Retinol and Derivatives Sales by Type (2026-2031) & (Tons)
Table 27. Global Retinol and Derivatives Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Retinol and Derivatives Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Retinol and Derivatives ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Retinol and Derivatives Sales by Application (2020-2025) & (Tons)
Table 32. Global Retinol and Derivatives Sales by Application (2026-2031) & (Tons)
Table 33. Retinol and Derivatives High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Retinol and Derivatives Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Retinol and Derivatives Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Retinol and Derivatives ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Retinol and Derivatives Growth Accelerators and Market Barriers
Table 40. North America Retinol and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Retinol and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Retinol and Derivatives Growth Accelerators and Market Barriers
Table 43. Europe Retinol and Derivatives Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Retinol and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Retinol and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Retinol and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Retinol and Derivatives Growth Accelerators and Market Barriers
Table 48. Southeast Asia Retinol and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Retinol and Derivatives Investment Opportunities and Key Challenges
Table 50. Central and South America Retinol and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Retinol and Derivatives Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Retinol and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. DSM Corporation Information
Table 54. DSM Description and Major Businesses
Table 55. DSM Product Models, Descriptions and Specifications
Table 56. DSM Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. DSM Sales Value Proportion by Product in 2024
Table 58. DSM Sales Value Proportion by Application in 2024
Table 59. DSM Sales Value Proportion by Geographic Area in 2024
Table 60. DSM Retinol and Derivatives SWOT Analysis
Table 61. DSM Recent Developments
Table 62. BASF Corporation Information
Table 63. BASF Description and Major Businesses
Table 64. BASF Product Models, Descriptions and Specifications
Table 65. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. BASF Sales Value Proportion by Product in 2024
Table 67. BASF Sales Value Proportion by Application in 2024
Table 68. BASF Sales Value Proportion by Geographic Area in 2024
Table 69. BASF Retinol and Derivatives SWOT Analysis
Table 70. BASF Recent Developments
Table 71. Evonik Corporation Information
Table 72. Evonik Description and Major Businesses
Table 73. Evonik Product Models, Descriptions and Specifications
Table 74. Evonik Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Evonik Sales Value Proportion by Product in 2024
Table 76. Evonik Sales Value Proportion by Application in 2024
Table 77. Evonik Sales Value Proportion by Geographic Area in 2024
Table 78. Evonik Retinol and Derivatives SWOT Analysis
Table 79. Evonik Recent Developments
Table 80. Zhejiang NHU Corporation Information
Table 81. Zhejiang NHU Description and Major Businesses
Table 82. Zhejiang NHU Product Models, Descriptions and Specifications
Table 83. Zhejiang NHU Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Zhejiang NHU Sales Value Proportion by Product in 2024
Table 85. Zhejiang NHU Sales Value Proportion by Application in 2024
Table 86. Zhejiang NHU Sales Value Proportion by Geographic Area in 2024
Table 87. Zhejiang NHU Retinol and Derivatives SWOT Analysis
Table 88. Zhejiang NHU Recent Developments
Table 89. Adisseo Corporation Information
Table 90. Adisseo Description and Major Businesses
Table 91. Adisseo Product Models, Descriptions and Specifications
Table 92. Adisseo Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Adisseo Sales Value Proportion by Product in 2024
Table 94. Adisseo Sales Value Proportion by Application in 2024
Table 95. Adisseo Sales Value Proportion by Geographic Area in 2024
Table 96. Adisseo Retinol and Derivatives SWOT Analysis
Table 97. Adisseo Recent Developments
Table 98. Zhejiang Pharmaceutical Corporation Information
Table 99. Zhejiang Pharmaceutical Description and Major Businesses
Table 100. Zhejiang Pharmaceutical Product Models, Descriptions and Specifications
Table 101. Zhejiang Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Zhejiang Pharmaceutical Recent Developments
Table 103. XIAMEN KINGDOMWAY VITAMIN Corporation Information
Table 104. XIAMEN KINGDOMWAY VITAMIN Description and Major Businesses
Table 105. XIAMEN KINGDOMWAY VITAMIN Product Models, Descriptions and Specifications
Table 106. XIAMEN KINGDOMWAY VITAMIN Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. XIAMEN KINGDOMWAY VITAMIN Recent Developments
Table 108. Salvona Technologies Corporation Information
Table 109. Salvona Technologies Description and Major Businesses
Table 110. Salvona Technologies Product Models, Descriptions and Specifications
Table 111. Salvona Technologies Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Salvona Technologies Recent Developments
Table 113. Piramal Group Corporation Information
Table 114. Piramal Group Description and Major Businesses
Table 115. Piramal Group Product Models, Descriptions and Specifications
Table 116. Piramal Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Piramal Group Recent Developments
Table 118. Tagra Biotechnologies Corporation Information
Table 119. Tagra Biotechnologies Description and Major Businesses
Table 120. Tagra Biotechnologies Product Models, Descriptions and Specifications
Table 121. Tagra Biotechnologies Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Tagra Biotechnologies Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Retinol and Derivatives Product Picture
Figure 2. Global Retinol and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Retinol Product Picture
Figure 4. Retinol Derivatives Product Picture
Figure 5. Global Retinol and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Animal Feed
Figure 7. Food
Figure 8. Cosmetics
Figure 9. Pharmaceuticals
Figure 10. Others
Figure 11. Retinol and Derivatives Report Years Considered
Figure 12. Global Retinol and Derivatives Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 14. Global Retinol and Derivatives Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Retinol and Derivatives Revenue Market Share by Region (2020-2031)
Figure 16. Global Retinol and Derivatives Sales (2020-2031) & (Tons)
Figure 17. Global Retinol and Derivatives Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Retinol and Derivatives Sales Market Share by Region (2020-2031)
Figure 19. Global Retinol and Derivatives Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Retinol and Derivatives Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Retinol and Derivatives Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Retinol and Derivatives Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Retinol and Derivatives Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Retinol and Derivatives Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Retinol and Derivatives Production Growth Rate in India (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Retinol and Derivatives Sales Volume Market Share in 2024
Figure 28. Global Retinol and Derivatives Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Retinol Revenue Market Share by Manufacturer in 2024
Figure 31. Retinol Derivatives Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global Retinol and Derivatives Sales Market Share by Type (2020-2031)
Figure 35. Global Retinol and Derivatives Revenue Market Share by Type (2020-2031)
Figure 36. Global Retinol and Derivatives Sales Market Share by Application (2020-2031)
Figure 37. Global Retinol and Derivatives Revenue Market Share by Application (2020-2031)
Figure 38. North America Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 39. North America Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 41. North America Retinol and Derivatives Sales Volume (Tons) by Type (2020- 2031)
Figure 42. North America Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 44. North America Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 46. Canada Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 48. Europe Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 49. Europe Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 51. Europe Retinol and Derivatives Sales Volume (Tons) by Type (2020-2031)
Figure 52. Europe Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 54. Europe Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 56. France Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 58. Italy Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 59. Russia Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 61. Asia-Pacific Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific Retinol and Derivatives Sales Volume (Tons) by Type (2020- 2031)
Figure 64. Asia-Pacific Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 66. Asia-Pacific Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 68. Japan Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 71. India Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 73. Central and South America Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America Retinol and Derivatives Sales Volume (Tons) by Type (2021-2031)
Figure 76. Central and South America Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 78. Central and South America Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 82. Middle East and Africa Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa Retinol and Derivatives Sales Volume (Tons) by Type (2021-2031)
Figure 85. South America Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 87. Middle East and Africa Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 92. Retinol and Derivatives Industry Chain Mapping
Figure 93. Regional Retinol and Derivatives Manufacturing Base Distribution (%)
Figure 94. Retinol and Derivatives Production Process
Figure 95. Regional Retinol and Derivatives Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
Table 1. Global Retinol and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Retinol and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Retinol and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Retinol and Derivatives Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Retinol and Derivatives Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Retinol and Derivatives Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Retinol and Derivatives Sales by Region (2020-2025) & (Tons)
Table 8. Global Retinol and Derivatives Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Retinol and Derivatives Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Retinol and Derivatives Production by Region (2020-2025) & (Tons)
Table 12. Global Retinol and Derivatives Production by Region (2026-2031) & (Tons)
Table 13. Global Retinol and Derivatives Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Retinol and Derivatives Sales Share by Manufacturers (2020-2025)
Table 15. Global Retinol and Derivatives Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Retinol and Derivatives Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Retinol and Derivatives by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinol and Derivatives as of 2024)
Table 19. Global Retinol and Derivatives Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Retinol and Derivatives Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Retinol and Derivatives Manufacturing Base and Headquarters
Table 22. Global Retinol and Derivatives Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Retinol and Derivatives Sales by Type (2020-2025) & (Tons)
Table 26. Global Retinol and Derivatives Sales by Type (2026-2031) & (Tons)
Table 27. Global Retinol and Derivatives Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Retinol and Derivatives Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Retinol and Derivatives ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Retinol and Derivatives Sales by Application (2020-2025) & (Tons)
Table 32. Global Retinol and Derivatives Sales by Application (2026-2031) & (Tons)
Table 33. Retinol and Derivatives High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Retinol and Derivatives Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Retinol and Derivatives Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Retinol and Derivatives ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Retinol and Derivatives Growth Accelerators and Market Barriers
Table 40. North America Retinol and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Retinol and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Retinol and Derivatives Growth Accelerators and Market Barriers
Table 43. Europe Retinol and Derivatives Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Retinol and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Retinol and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Retinol and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Retinol and Derivatives Growth Accelerators and Market Barriers
Table 48. Southeast Asia Retinol and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Retinol and Derivatives Investment Opportunities and Key Challenges
Table 50. Central and South America Retinol and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Retinol and Derivatives Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Retinol and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. DSM Corporation Information
Table 54. DSM Description and Major Businesses
Table 55. DSM Product Models, Descriptions and Specifications
Table 56. DSM Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. DSM Sales Value Proportion by Product in 2024
Table 58. DSM Sales Value Proportion by Application in 2024
Table 59. DSM Sales Value Proportion by Geographic Area in 2024
Table 60. DSM Retinol and Derivatives SWOT Analysis
Table 61. DSM Recent Developments
Table 62. BASF Corporation Information
Table 63. BASF Description and Major Businesses
Table 64. BASF Product Models, Descriptions and Specifications
Table 65. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. BASF Sales Value Proportion by Product in 2024
Table 67. BASF Sales Value Proportion by Application in 2024
Table 68. BASF Sales Value Proportion by Geographic Area in 2024
Table 69. BASF Retinol and Derivatives SWOT Analysis
Table 70. BASF Recent Developments
Table 71. Evonik Corporation Information
Table 72. Evonik Description and Major Businesses
Table 73. Evonik Product Models, Descriptions and Specifications
Table 74. Evonik Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Evonik Sales Value Proportion by Product in 2024
Table 76. Evonik Sales Value Proportion by Application in 2024
Table 77. Evonik Sales Value Proportion by Geographic Area in 2024
Table 78. Evonik Retinol and Derivatives SWOT Analysis
Table 79. Evonik Recent Developments
Table 80. Zhejiang NHU Corporation Information
Table 81. Zhejiang NHU Description and Major Businesses
Table 82. Zhejiang NHU Product Models, Descriptions and Specifications
Table 83. Zhejiang NHU Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Zhejiang NHU Sales Value Proportion by Product in 2024
Table 85. Zhejiang NHU Sales Value Proportion by Application in 2024
Table 86. Zhejiang NHU Sales Value Proportion by Geographic Area in 2024
Table 87. Zhejiang NHU Retinol and Derivatives SWOT Analysis
Table 88. Zhejiang NHU Recent Developments
Table 89. Adisseo Corporation Information
Table 90. Adisseo Description and Major Businesses
Table 91. Adisseo Product Models, Descriptions and Specifications
Table 92. Adisseo Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Adisseo Sales Value Proportion by Product in 2024
Table 94. Adisseo Sales Value Proportion by Application in 2024
Table 95. Adisseo Sales Value Proportion by Geographic Area in 2024
Table 96. Adisseo Retinol and Derivatives SWOT Analysis
Table 97. Adisseo Recent Developments
Table 98. Zhejiang Pharmaceutical Corporation Information
Table 99. Zhejiang Pharmaceutical Description and Major Businesses
Table 100. Zhejiang Pharmaceutical Product Models, Descriptions and Specifications
Table 101. Zhejiang Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Zhejiang Pharmaceutical Recent Developments
Table 103. XIAMEN KINGDOMWAY VITAMIN Corporation Information
Table 104. XIAMEN KINGDOMWAY VITAMIN Description and Major Businesses
Table 105. XIAMEN KINGDOMWAY VITAMIN Product Models, Descriptions and Specifications
Table 106. XIAMEN KINGDOMWAY VITAMIN Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. XIAMEN KINGDOMWAY VITAMIN Recent Developments
Table 108. Salvona Technologies Corporation Information
Table 109. Salvona Technologies Description and Major Businesses
Table 110. Salvona Technologies Product Models, Descriptions and Specifications
Table 111. Salvona Technologies Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Salvona Technologies Recent Developments
Table 113. Piramal Group Corporation Information
Table 114. Piramal Group Description and Major Businesses
Table 115. Piramal Group Product Models, Descriptions and Specifications
Table 116. Piramal Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Piramal Group Recent Developments
Table 118. Tagra Biotechnologies Corporation Information
Table 119. Tagra Biotechnologies Description and Major Businesses
Table 120. Tagra Biotechnologies Product Models, Descriptions and Specifications
Table 121. Tagra Biotechnologies Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Tagra Biotechnologies Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Retinol and Derivatives Product Picture
Figure 2. Global Retinol and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Retinol Product Picture
Figure 4. Retinol Derivatives Product Picture
Figure 5. Global Retinol and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Animal Feed
Figure 7. Food
Figure 8. Cosmetics
Figure 9. Pharmaceuticals
Figure 10. Others
Figure 11. Retinol and Derivatives Report Years Considered
Figure 12. Global Retinol and Derivatives Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 14. Global Retinol and Derivatives Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Retinol and Derivatives Revenue Market Share by Region (2020-2031)
Figure 16. Global Retinol and Derivatives Sales (2020-2031) & (Tons)
Figure 17. Global Retinol and Derivatives Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Retinol and Derivatives Sales Market Share by Region (2020-2031)
Figure 19. Global Retinol and Derivatives Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Retinol and Derivatives Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Retinol and Derivatives Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Retinol and Derivatives Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Retinol and Derivatives Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Retinol and Derivatives Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Retinol and Derivatives Production Growth Rate in India (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Retinol and Derivatives Sales Volume Market Share in 2024
Figure 28. Global Retinol and Derivatives Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Retinol Revenue Market Share by Manufacturer in 2024
Figure 31. Retinol Derivatives Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global Retinol and Derivatives Sales Market Share by Type (2020-2031)
Figure 35. Global Retinol and Derivatives Revenue Market Share by Type (2020-2031)
Figure 36. Global Retinol and Derivatives Sales Market Share by Application (2020-2031)
Figure 37. Global Retinol and Derivatives Revenue Market Share by Application (2020-2031)
Figure 38. North America Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 39. North America Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 41. North America Retinol and Derivatives Sales Volume (Tons) by Type (2020- 2031)
Figure 42. North America Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 44. North America Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 46. Canada Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 48. Europe Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 49. Europe Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 51. Europe Retinol and Derivatives Sales Volume (Tons) by Type (2020-2031)
Figure 52. Europe Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 54. Europe Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 56. France Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 58. Italy Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 59. Russia Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 61. Asia-Pacific Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific Retinol and Derivatives Sales Volume (Tons) by Type (2020- 2031)
Figure 64. Asia-Pacific Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 66. Asia-Pacific Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 68. Japan Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 71. India Retinol and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 73. Central and South America Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America Retinol and Derivatives Sales Volume (Tons) by Type (2021-2031)
Figure 76. Central and South America Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 78. Central and South America Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa Retinol and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 82. Middle East and Africa Retinol and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers Retinol and Derivatives Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa Retinol and Derivatives Sales Volume (Tons) by Type (2021-2031)
Figure 85. South America Retinol and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa Retinol and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 87. Middle East and Africa Retinol and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa Retinol and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 92. Retinol and Derivatives Industry Chain Mapping
Figure 93. Regional Retinol and Derivatives Manufacturing Base Distribution (%)
Figure 94. Retinol and Derivatives Production Process
Figure 95. Regional Retinol and Derivatives Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232